Media center

30 June 2025 - The International Planned Parenthood Federation (IPPF) is proud to announce the roll out of CAB-LA (cabotegravir-long acting), a form of pre-exposure prophylaxis (PrEP) for HIV, in Eswatini, and Malawi, and a pilot project in Lesotho - a major milestone in the fight against HIV. IPPF Member Associations (MAs) in the three countries - Family Life Association of Eswatini (FLAS), Lesotho Planned Parenthood Association (LPPA), and Family Planning Association of Malawi ( FPAM) will soon begin to distribute CAB-LA for HIV prevention to individuals who would like to use this form of HIV prevention.  CAB-LA, a long-acting injectable PrEP, is a game changer for HIV prevention. PrEP is an HIV prevention method where HIV-negative individuals take medication to significantly reduce their risk of acquiring HIV. Administered every 8 weeks, CAB-LA greatly reduces infection risk and does not rely on remembering to take a daily pill, addressing adherence challenges faced by some people using oral PrEP.  This roll-out comes when US budget cuts have severely impacted governments and organizations providing sexual and reproductive health services, HIV prevention, and humanitarian aid. These financial restrictions have significantly impacted access to essential sexual and reproductive health medications globally, compromising HIV prevention and treatment for many, especially those most in need. The arrival of CAB-LA is a major step forward in the fight against HIV/AIDS, providing longer-term protection, a more convenient option, and a discreet alternative to daily pills. Family Life Association of Eswatini, Lesotho Planned Parenthood Association, and the Family Planning Association of Malawi will be providing CAB-LA for PrEP through their static clinics and other public service delivery points. This effort underscores the vital role our MAs play in securing and delivering universal access to sexual and reproductive healthcare. For more information, please contact media@ippf.orgAbout the International Planned Parenthood Federation  IPPF is a global healthcare provider and a leading advocate of sexual and reproductive health and rights (SRHR) for all. Led by a courageous and determined group of women, IPPF was founded in 1952 at the Third International Planned Parenthood Conference. Today, we are a movement of 158 Member Associations and Collaborative Partners with a presence in over 153 countries.  Our work is wide-ranging, and includes services for sexual health and well-being, contraception, abortion care, sexually transmitted infections and reproductive tract infections, HIV, obstetrics and gynecology, fertility support, sexual and gender-based violence, comprehensive sex education, and responding to humanitarian crises. We pride ourselves on being local through our members and global through our network. At the heart of our mission is the provision of – and advocacy in support of – integrated healthcare to anyone who needs it regardless of race, gender, sex, income, and, crucially no matter how remote.  

Joint statement by FCAA, IPPF, and ILGA-World from the Kalavai Partnership31 March 2025 -  We call on policymakers, governments, and philanthropy to protect and expand HIV funding and not to turn their backs on vulnerable populations.The world is at a crossroads in the fight against HIV. For decades, dedicated investments in HIV prevention, treatment, and care have saved millions of lives and helped stabilize communities. Yet today, these gains are at risk. Critical funding from the U.S. government and other donor nations is under threat, jeopardizing the very infrastructure that has driven progress.In fact, new analyses published by amfAR and The Lancet demonstrate the catastrophic toll cuts to both the U.S. CDC Division of HIV Prevention and foreign aid from the US, the Netherlands, Britain, and other nations, predicting up to 2.9 million more HIV-related deaths before 2030 and essentially undoing all progress achieved since 2000.This crisis no longer knows borders. Now is the time to act—before we lose ground that cannot easily be regained.HIV Prevention Saves Lives—We Must Not Step BackHIV prevention is one of the most cost-effective and impactful investments in global health. It reduces new infections, alleviates the burden on healthcare systems, and safeguards the well-being of vulnerable communities. U.S. government funding for global HIV programs has been a lifeline for communities disproportionately affected by HIV, including women and children, LGBTQ people, sex workers, and people who use drugs. Yet today, political and financial pressures threaten these programs, putting lives and progress in jeopardy.HIV prevention includes a broad range of essential interventions:Access to PrEP (Pre-Exposure Prophylaxis): A highly effective HIV prevention medication that significantly reduces the risk of transmission.Comprehensive sexual health education: Ensuring individuals have the knowledge and resources to protect themselves and their partners.Harm reduction services: Including needle exchange programs and opioid substitution therapy for people who use drugs.Access to condoms and lubricants: Fundamental tools in preventing the spread of HIV and other sexually transmitted infections.HIV testing and linkage to care: Early diagnosis and immediate access to treatment are key to preventing new infections and achieving viral suppression.Mother-to-child transmission prevention: Ensuring pregnant women living with HIV have access to antiretroviral therapy to protect their newborns.HIV, Global Health Security, and Human Rights Are InseparableHIV prevention is not just about health — it is about global stability, economic resilience, and human rights.Slashing funding for HIV programs weakens public health infrastructure, rolling back decades of hard-won progress and making people worldwide more vulnerable to other global health crises.The fight against HIV is intrinsically linked to sexual and reproductive health and rights, women's health, and LGBTQ rights. For example, the lives of transgender individuals are even more at risk due to the reduction of health and human rights-based services as a result of anti-trans and anti-DEI Executive Orders.Women and girls continue to bear a disproportionate burden of the HIV epidemic, and their health hangs in the balance in the wake of funding cuts. Every week, approximately 4,000 adolescent girls and young women contract HIV, the majority of whom live in sub-Saharan Africa. Pregnant women living with HIV require consistent treatment to prevent mother-to-child transmission, yet funding shortfalls place these essential services at risk. Without sustained investment, millions of women and newborns face heightened health risks, undermining global progress toward ending HIV.Governments and donors must recognize that investing in HIV prevention is an investment in global health security. When we protect and strengthen HIV infrastructure, we also reinforce systems that respond to pandemics, reduce maternal mortality, and promote equity in healthcare.A Call to Action: The Time to Step Up is NowWe have the medical tools - including the addition of long-acting injectables - to end HIV as a public health crisis. We just need the funding and leadership.We call on policymakers in the U.S. government and donor governments worldwide to take urgent action:Sustain and increase funding for HIV prevention, treatment, and care. Public investment is essential to protect the communities most at risk and ensure that we don’t lose ground.Recognize the intersection of HIV with broader human rights issues. Supporting HIV programs also means protecting reproductive health, LGBTQ rights, and gender justice.We also call on philanthropy to lean in, not out. Now is not the time for donors to retreat. The role of private philanthropy has never been more critical in safeguarding communities and mobilizing new resources to fill funding gaps. Every investment today saves lives tomorrow.The Kalavai Initiative — a partnership of Funders Concerned About AIDS (FCAA), the International Planned Parenthood Federation (IPPF), Global Philanthropy Project (GPP), and ILGA World — urges all stakeholders to act with urgency. Lives are at stake. The time to protect and expand HIV funding is now.Join Us in Taking ActionPolicymakers, donors, and advocates: Stand with us to protect public health, human rights, and the future of HIV prevention. Together, we can ensure that decades of progress are not lost, and that every person — regardless of who they are or where they live — has access to the lifesaving care they deserve.About the Kalavai Partners:ILGA World is a worldwide federation of more than 2,000 organisations from over 170 countries and territories campaigning for the human rights of people with diverse sexual orientations, gender identities and expressions, and sex characteristics. https://ilga.orgThe International Planned Parenthood Federation (IPPF) is a global healthcare provider and a leading advocate of sexual and reproductive health and rights (SRHR) for all. Founded in 1952, it is now a movement of 150 member associations and collaborative partners with a presence in over 146 countries. https://www.ippf.org/Funders Concerned About AIDS (FCAA) unites philanthropic leaders to pursue a shared vision of a world without AIDS. Through research, advocacy, and collaboration, we work to mobilize and grow funding for the ever-changing fight against HIV. https://www.fcaaids.org/Global Philanthropy Project (GPP) is a collaboration of funders and philanthropic advisors working to expand global philanthropic support to advance the human rights of lesbian, gay, bisexual, transgender, and intersex (LGBTI) people in the Global South and East. https://globalphilanthropyproject.org/

Eswatini (27 August 2024) - IPPF’s Member Association in Eswatini, the Family Life Association of Eswatini (FLAS), is soon to roll out the first women-controlled HIV prevention product, the dapivirine vaginal ring (DVR). FLAS will be among the first organisations to offer the DVR outside implementation or pilot studies anywhere in the world. Made of flexible silicone, the ring is inserted into the vagina by a woman and slowly releases the antiretroviral drug dapivirine in the vagina over a one-month period, helping to reduce a woman’s risk of acquiring HIV. In 2023, in sub-Saharan Africa, women and girls accounted for 62% of all new HIV infections and every week, 3,100 adolescent girls and young women aged 15–24 years became infected with HIV. Therefore, there continues to be an urgent need for HIV prevention methods that females can use to protect themselves. The DVR is a product women can control themselves and use without the knowledge or consent of their partners, unlike condoms, which men often refuse to use. The DVR is inserted into the vagina and left for a one-month period, where it can then be replaced each month for continued protection. Unlike daily oral PrEP, the DVR does not rely on remembering to take a pill each day and is also discreet as it stays inside the vagina throughout the month. The DVR does not prevent pregnancy or other sexually transmitted infections (STIs), so women choosing to use the ring may want to consider combining it with condoms and methods of contraception. The availability of the DVR is an exciting step in supporting women’s autonomy and choice in HIV prevention. This need for women-controlled HIV prevention products has long been advocated for, with the African Women Prevention Community Accountability Board launching the HIV Prevention Choice Manifesto in early 2023. The Choice Manifesto prioritises the principle of choice to ensure that women and girls have the right to choose which HIV prevention methods work for them. Currently the ring is available at selected facilities through implementation studies across six countries in East and Southern Africa; South Africa, Kenya, Zimbabwe, Lesotho, Eswatini, and Uganda.  Diantha Pillay, Associate Director for Product Access for IPM South Africa NPC (an affiliate of the Population Council), said:  “It is encouraging to see the efforts made by FLAS and IPPF to support the choice agenda for HIV prevention for women and make effective HIV prevention methods, like the DVR, more widely accessible in a real-world setting. We hope this can pave the way for introduction of future pipeline products that speak to the needs of women.” The Population Council is currently developing a longer duration DVR that women would use for three months versus one month to significantly lower annual product costs and offer women a more convenient option to protect themselves. Thabo Lizwe Masuku, Programs Manager for FLAS, said: “Women have been telling us for a long time that  there is a need for a variety of methods for HIV prevention, since they are highly exposed. For women and girls to truly have choice about what works for them as they navigate different stages and circumstances of their lives, policy makers, donors, governments and implementers must ensure the mix of HIV prevention methods are available, accessible, and affordable. Access to the ring through our clinics in Eswatini now gives women choice and options to protect themselves against HIV.” IPPF is committed to ensuring that choice in HIV prevention is a reality for women and girls and aims to roll out the dapivirine vaginal rings at as many Member Associations as possible, as well as offer other HIV-prevention choices, as we work alongside our partners towards a future free of HIV in Africa and beyond. For more information and to speak to staff in Eswatini, please email media@ippf.org   Notes: The dapivirine vaginal ring has been recommended by the WHO since January 2021. (25) In clinical trials, the  ring was shown to reduce HIV infection by 35% in The Ring Study (26,27) and 27% in the ASPIRE Study. (28,29) Recent open-label studies show greater adherence to the ring, and modelling data suggest that HIV risk could be reduced by about 50%. (30) The dapivirine ring has received regulatory approval from the European Medicines Agency (EMA), as well as from local medicines regulators in Namibia, South Africa, Kenya, Zimbabwe, Uganda, Zambia, Malawi, Rwanda, Eswatini, Lesotho, Botswana and is currently under regulatory review in a number of other countries Our Member Associations (MAs) that provide clinical services are required to provide comprehensive SRH services through our Integrated Package of Essential Services (IPES) which include services for sexual health and well-being, contraception, abortion care, sexually transmitted infections (STIs)/reproductive tract infections (RTIs), HIV, obstetrics and gynaecology, fertility support, and sexual and gender-based violence. IPPF’s new five-year strategy, Come Together, focuses on expanding choice. In support of this, we recently launched a special programme to expand our HIV prevention options, which aims to integrate the newest HIV prevention methods – the vaginal ring and injectable PrEP - into our comprehensive sexual and reproductive health services.  IPPF’s IMAP Statement on Biomedical HIV Prevention can be found here. About the Family Life Association of Eswatini (FLAS)  For over 30 years, the Family Life Association of Eswatini (FLAS) has provided sexual and reproductive health (SRH) services to the people of Eswatini (formally Swaziland). While family planning, antenatal, post-natal and post-abortion care form a key part of FLAS services, there’s a significant focus on HIV and AIDS programmes. Eswatini has some of the highest HIV and AIDS prevalence rates in the world. As a result, the prevention and management of HIV and AIDS, the provision of voluntary counselling and testing (VCT), and the prevention of mother to child transmission (PMTCT) are central to FLAS’s work. FLAS has 15 service points, including three permanent clinics and three mobile facilities, staffed by a permanent team of 40 staff backed by 230 volunteers, 180 Youth Action Movement members and 29 peer educators. About the International Planned Parenthood Federation (IPPF) IPPF is a global healthcare provider and a leading advocate of sexual and reproductive health and rights (SRHR) for all. Led by a courageous and determined group of women, IPPF was founded in 1952 at the Third International Planned Parenthood Conference. Today, we are a movement of 150 Member Associations and Collaborative Partners with a presence in over 146 countries.Our work is wide-ranging, including comprehensive sex education, provision of contraceptives, safe abortion, and maternal care and responding to humanitarian crises.  We pride ourselves on being local through our members and global through our network. At the heart of our mission is the provision of – and advocacy in support of – integrated healthcare to anyone who needs it regardless of race, gender, sex, income, and crucially no matter how remote. Our services are available to all, and reach the most marginalised groups in societies, including key and priority populations, youth, and people with disabilities. Most of our MAs have special programs to engage youth (10-24) inside and outside of school settings. Because our clinics offer comprehensive services, attending our clinics is non-stigmatizing and does not label people as having a particular disease or membership to a particular group. This model of services that are integrated and open to all, embedded in indigenous, locally owned organisations, is ideal for ensuring that the most vulnerable and marginalised groups can access the HIV prevention services they need. About the Population Council The Population Council is a leading research organization dedicated to building an equitable and sustainable world that enhances the health and well-being of current and future generations. The Council transforms global thinking on critical health and development issues through social science, public health, and biomedical research. We generate ideas, produce evidence, and design solutions to improve the lives of underserved populations around the world.  

The Director General of the International Planned Parenthood Federation (IPPF), Dr Alvaro Bermejo, is in Australia this week for high level meetings with Australian Government Ministers and the Australian Department of Foreign Affairs and Trade (DFAT). He is joined by Ms Tomoka Fukuda, Regional Director of IPPF’s East and Southeast Asia and Oceania Region (ESEAOR) and Ms Phoebe Ryan, IPPF’s Chief of the Australia and New Zealand Office. In Australia, Dr Bermejo has been privileged to meet with Australia’s Minister for International Development and the Pacific, the Hon Pat Conroy. Together, they discussed how Australia can play a leadership role in advancing sexual and reproductive health and rights through Australia’s international development cooperation. Last week, Dr Bermejo and Ms Fukuda visited IPPF’s Member Association in Solomon Islands, the Solomon Islands Planned Parenthood Association (SIPPA). In Solomon Islands, they witnessed SIPPA’s life-saving and critical work delivering sexual and reproductive healthcare on the ground, including mobile outreach in remote communities of Malaita Province. Australia has been a long-standing and critical partner to IPPF, supporting programming to reach women, girls, and marginalized groups across the development–humanitarian continuum around the world, with a particular focus on the Asia Pacific. In December 2022, IPPF and DFAT signed a new four-year global funding agreement for 2023 to 2026, part of which includes dedicated support to programming across the Pacific. AUD 19 million is dedicated as global funding towards the delivery of IPPF’s Strategy 2028, along with a further AUD 5.7 million to support the delivery of IPPF’s Pacific Niu Vaka Strategy, Phase 2. This generous investment will enable IPPF to reach an anticipated 1.8 million people in the Pacific over the next six years with 4.2 million essential sexual and reproductive services. IPPF is proud to stand alongside our Pacific MAs as they continue to advocate for the health and rights of those most underserved and excluded, reaching communities with essential information and high quality, person-centred sexual and reproductive health care.     In 2021, IPPF reached over 72 million people around the world with more than 155 million sexual and reproductive health services and contributed to 121 policy and legislative changes in defence of SRHR. IPPF is grateful for Australia’s ongoing support in enabling this impact. IPPF’s Director General, Alvaro Bermejo shared: “IPPF are delighted to be working with the Australian Government to continue improving the sexual and reproductive health and rights (SRHR) of women and girls across the globe. We are grateful to them for helping us deliver more services and support at a time when inequalities are deepening, the opposition is growing, and humanitarian crises continue to place the lives of millions, particularly women and girls, at risk. As we look to build the future with our new strategy, continued support from global partners is crucial to achieving a world where everyone has access to sexual and reproductive healthcare. We hope DFAT’s strong global commitment will inspire other global leaders to take action.” For media enquiries, please contact Karmen Ivey on kivey@ippf.org or Phoebe Ryan on pryan@ippf.org    About the International Planned Parenthood Federation The International Planned Parenthood Federation (IPPF) is a global service provider and advocate of sexual and reproductive health and rights for all.  For 70 years, IPPF has delivered high-quality sexual and reproductive healthcare and helped advance sexual rights, especially for people with intersectional and diverse needs that are currently unmet. Our Member Associations and partners are independent organizations that are locally owned, which means the support and care they provide is informed by local expertise and context. We advocate for a world where people are provided with the information they need to make informed decisions about their sexual health and bodies. We stand up and fight for sexual and reproductive rights and against those who seek to deny people their human right to bodily autonomy and freedom. We deliver care that is rooted in rights, respect, and dignity - no matter what.